Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reimbursement: The New Biopharma Investment Hurdle

01 Jun 2010

Related Content

NitroMed's BiDil Pricing: Test for a Whole Class of New Companies

01 Oct 2005

Market Snapshot: Anti-TNFs Grow Despite Tough Market

08 Dec 2008

Exploring the Full Potential of Risk-Sharing Agreements Between Pharma Companies and Payors

01 May 2010

Pharma's New Follow-On Strategy

01 Feb 2008

UK's NICE Says No To Two CML Drugs; Invites Cost-Sharing Schemes

15 Feb 2010

Building A Biopharma Product's Reimbursement Into Deals

01 Mar 2010

Related Companies

NitroMed, Inc.

Amgen, Inc.

Pfizer Inc.

Abbott

Bristol Myers Squibb Company

Novartis AG

Bayer AG

Onyx Pharmaceuticals, Inc.

Roche Holding AG

General Electric

General Electric

Photocure ASA

Additional Topics

Business Strategies Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.